Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

82 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Preclinical safety evaluation of subretinal AAV2.sFlt-1 in non-human primates.
Lai CM, Estcourt MJ, Himbeck RP, Lee SY, Yew-San Yeo I, Luu C, Loh BK, Lee MW, Barathi A, Villano J, Ang CL, van der Most RG, Constable IJ, Dismuke D, Samulski RJ, Degli-Esposti MA, Rakoczy EP. Lai CM, et al. Among authors: van der most rg. Gene Ther. 2012 Oct;19(10):999-1009. doi: 10.1038/gt.2011.169. Epub 2011 Nov 10. Gene Ther. 2012. PMID: 22071974
Gene therapy of mesothelioma.
Nelson DJ, Robinson BW, Allan J, van der Most R. Nelson DJ, et al. Expert Opin Biol Ther. 2005 Aug;5(8):1039-49. doi: 10.1517/14712598.5.8.1039. Expert Opin Biol Ther. 2005. PMID: 16050782 Review.
Tumor eradication after cyclophosphamide depends on concurrent depletion of regulatory T cells: a role for cycling TNFR2-expressing effector-suppressor T cells in limiting effective chemotherapy.
van der Most RG, Currie AJ, Mahendran S, Prosser A, Darabi A, Robinson BW, Nowak AK, Lake RA. van der Most RG, et al. Cancer Immunol Immunother. 2009 Aug;58(8):1219-28. doi: 10.1007/s00262-008-0628-9. Epub 2008 Dec 4. Cancer Immunol Immunother. 2009. PMID: 19052741
82 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page